Giri N, Davis E A, Vowels M R
Department of Paediatric Haematology/Oncology, Prince of Wales Children's Hospital, Randwick, New South Wales, Australia.
J Paediatr Child Health. 1993 Jun;29(3):201-5. doi: 10.1111/j.1440-1754.1993.tb00487.x.
Seventeen children who underwent bone marrow transplantation (BMT) between 1975 and 1985 and survived for more than 2 years were evaluated for growth and development. The patients had a follow up of 2.1-13.1 years. Prior to transplant, children with malignancy had received multi-agent chemotherapy and nine had also received central nervous system irradiation. Transplant preparation for malignancy (group 1; n = 13) included high-dose cyclophosphamide (CPA) 120-200 mg/kg and total body irradiation (TBI) 10-13.2 Gy, whereas conditioning for non-malignant disorders (group 2; n = 4) included high-dose CPA 200 mg/kg with or without busulphan. Patients in group 1 showed a steady decline in height velocity following initial chemotherapy and cranial irradiation and the decline was even greater following BMT. Growth hormone (GH) deficiency developed in eight of nine children tested, hypergonadotrophic hypogonadism developed in 11 who reached puberty, thyroid hormone abnormalities were encountered in four out of 10 tested and 11 of 13 developed cataracts. Patients in group 2 did not show decline in linear growth rate, thyroid hormone abnormalities or cataracts after BMT. The only child tested had normal GH levels and the two patients who reached puberty showed delayed but complete gonadal recovery. Our data demonstrate that TBI leads to significant late effects on growth and gonadal function. Contrary to previous reports, a high incidence of cataract formation is observed after fractionated TBI. Conditioning regimens TBI should be considered in children undergoing BMT.
对1975年至1985年间接受骨髓移植(BMT)且存活超过2年的17名儿童进行了生长发育评估。这些患者的随访时间为2.1至13.1年。移植前,患有恶性肿瘤的儿童接受了多药化疗,其中9名还接受了中枢神经系统照射。针对恶性肿瘤的移植预处理(第1组;n = 13)包括高剂量环磷酰胺(CPA)120 - 200 mg/kg和全身照射(TBI)10 - 13.2 Gy,而针对非恶性疾病的预处理(第2组;n = 4)包括高剂量CPA 200 mg/kg,加或不加白消安。第1组患者在初始化疗和颅脑照射后身高增长速度稳步下降,BMT后下降更为明显。在接受检测的9名儿童中有8名出现生长激素(GH)缺乏,11名进入青春期的儿童出现高促性腺激素性性腺功能减退,10名接受检测的儿童中有4名出现甲状腺激素异常,13名中有11名出现白内障。第2组患者在BMT后未出现线性生长速度下降、甲状腺激素异常或白内障。唯一接受检测的儿童GH水平正常,两名进入青春期的患者性腺恢复延迟但完全。我们的数据表明,TBI会对生长和性腺功能产生显著的晚期影响。与先前的报道相反,分次TBI后观察到白内障形成的高发生率。接受BMT的儿童应考虑采用含TBI的预处理方案。